|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:2817–30. 2013. View Article : Google Scholar
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Minna JD, Roth JA and Gazdar AF: Focus on
lung cancer. Cancer Cell. 1:49–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
International Early Lung Cancer Action
Program Investigators, ; Henschke CI, Yankelevitz DF, Libby DM,
Pasmantier MW, Smith JP and Miettinen OS: Survival of patients with
stage I lung cancer detected on CT screening. N Engl J Med.
355:1763–1771. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma Y, Pan X, Xu P, Mi Y, Wang W, Wu X, He
Q, Liu X, Tang W and An HX: Plasma microRNA alterations between
EGFR-activating mutational NSCLC patients with and without primary
resistance to TKI. Oncotarget. 8:88529–88536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krentz Gober M, Collard JP, Thompson K and
Black EP: A microRNA signature of response to erlotinib is
descriptive of TGFβ behaviour in NSCLC. Sci Rep. 7:42022017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui Y, Zhao L, Zhao S, Guo T, Li F, Li Z,
Fang L, Wu T and Gu C: MicroRNA-30e inhibits proliferation and
invasion of non-small cell lung cancer via targeting SOX9. Hum
Cell. 32:326–333. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu F, Cai Y, Rong X, Chen J, Zheng D,
Chen L, Zhang J, Luo R, Zhao P and Ruan J: miR-661 promotes tumor
invasion and metastasis by directly inhibiting RB1 in non small
cell lung cancer. Mol Cancer. 16:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu PJ, Ye YX, Wang YX, Du JX, Pan YH and
Fang XB: miRNA-92a promotes cell proliferation and invasion through
binding to KLF4 in glioma. Eur Rev Med Pharmacol Sci. 23:6612–6620.
2019.PubMed/NCBI
|
|
12
|
Yu H, Song H, Liu L, Hu S, Liao Y, Li G,
Xiao X, Chen X and He S: miR-92a modulates proliferation,
apoptosis, migration, and invasion of osteosarcoma cell lines by
targeting Dickkopf-related protein 3. Biosci Rep.
39:BSR201904102019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shigoka M, Tsuchida A, Matsudo T, Nagakawa
Y, Saito H, Suzuki Y, Aoki T, Murakami Y, Toyoda H, Kumada T, et
al: Deregulation of miR-92a expression is implicated in
hepatocellular carcinoma development. Pathol Int. 60:351–357. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen E, Li Q, Wang H, Yang F, Min L and
Yang J: miR-92a promotes tumorigenesis of colorectal cancer, a
transcriptomic and functional based study. Biomed Pharmacother.
106:1370–1377. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang X, Li X, Wu F, Gao H, Wang G, Zheng
H, Wang H, Li J and Chen C: Overexpression of miR-92a promotes the
tumor growth of osteosarcoma by suppressing F-box and WD
repeat-containing protein 7. Gene. 606:10–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu Q, Zang Q and Jiang ZM: Enhanced
expression of non coding miR 92a expression is implicated in the
development of lung cancer. Eur Rev Med Pharmacol Sci.
22:1028–1034. 2018.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Y, Zuo J, Tan Q, Zar Thin K, Li P, Zhu
M, Yu M, Fu Z, Liang C and Tu J: Plasma miR-92a-2 as a biomarker
for small cell lung cancer. Cancer Biomark. 18:319–327. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Coşarcă AS, Mocan SL, Păcurar M, Fülöp E
and Ormenişan A: The evaluation of Ki67, p53, MCM3 and PCNA
immunoexpressions at the level of the dental follicle of impacted
teeth, dentigerous cysts and keratocystic odontogenic tumors. Rom J
Morphol Embryol. 57:407–412. 2016.PubMed/NCBI
|
|
20
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nasser MW, Datta J, Nuovo G, Kutay H,
Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang
X, Xiong H, Gurbani D, Li L, Liu Y and Liu A: MicroRNA-218
functions as a tumor suppressor in lung cancer by targeting
IL-6/STAT3 and negatively correlates with poor prognosis. Mol
Cancer. 16:1412017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhuang Z, Sun C and Gong H: High serum
miR-484 expression is associated with the diagnosis and prognosis
of patients with non-small cell lung cancer. Exp Ther Med.
18:4095–4102. 2019.PubMed/NCBI
|
|
26
|
Li M, Guan X, Sun Y, Mi J, Shu X, Liu F
and Li C: miR-92a family and their target genes in tumorigenesis
and metastasis. Exp Cell Res. 323:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo J, Wen N, Yang S, Guan X and Cang S:
miR-92a regulates oral squamous cell carcinoma (OSCC) cell growth
by targeting FOXP1 expression. Biomed Pharmacother. 104:77–86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ke TW, Wei PL, Yeh KT, Chen WT and Cheng
YW: miR-92a promotes cell metastasis of colorectal cancer through
PTEN-mediated PI3K/AKT pathway. Ann Surg Oncol. 22:2649–2655. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bae S, Lee EM, Cha HJ, Kim K, Yoon Y, Lee
H, Kim J, Kim YJ, Lee HG, Jeung HK, et al: Resveratrol alters
microRNA expression profiles in A549 human non-small cell lung
cancer cells. Mol Cells. 32:243–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao J, Fu W, Liao H, Dai L, Jiang Z, Pan
Y, Huang H, Mo Y, Li S, Yang G and Yin J: The regulatory and
predictive functions of miR-17 and miR-92 families on cisplatin
resistance of non-small cell lung cancer. BMC Cancer. 15:7312015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu C, Shan Z, Hong J and Yang L:
MicroRNA-92a promotes epithelial-mesenchymal transition through
activation of PTEN/PI3K/AKT signaling pathway in non-small cell
lung cancer metastasis. Int J Oncol. 51:235–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Minella AC and Clurman BE: Mechanisms of
tumor suppression by the SCF(Fbw7). Cell Cycle. 4:1356–1359. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Z, Xiao J, Hu K, Wang G, Li M, Zhang J
and Cheng G: FBXW7 acts as an independent prognostic marker and
inhibits tumor growth in human osteosarcoma. Int J Mol Sci.
16:2294–2306. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiao Y, Yin C, Wang Y, Lv H, Wang W, Huang
Y, Perez-Losada J, Snijders AM, Mao JH and Zhang P: FBXW7 deletion
contributes to lung tumor development and confers resistance to
gefitinib therapy. Mol Oncol. 12:883–895. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou C, Shen L, Mao L, Wang B, Li Y and Yu
H: miR-92a is upregulated in cervical cancer and promotes cell
proliferation and invasion by targeting FBXW7. Biochem Biophys Res
Commun. 458:63–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng
X and Tu K: MicroRNA-92a contributes to tumor growth of human
hepatocellular carcinoma by targeting FBXW7. Oncol Rep.
34:2576–2584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ren P, Gong F, Zhang Y, Jiang J and Zhang
H: MicroRNA-92a promotes growth, metastasis, and chemoresistance in
non-small cell lung cancer cells by targeting PTEN. Tumour Biol.
37:3215–3225. 2016. View Article : Google Scholar : PubMed/NCBI
|
